RiverVest Venture Management’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.31M | Hold |
253,422
| – | – | 63% | 1 |
|
|
2024
Q2 | $3.83M | Hold |
253,422
| – | – | 56.07% | 1 |
|
|
2024
Q1 | $4.21M | Hold |
253,422
| – | – | 51.67% | 1 |
|
|
2023
Q4 | $4.05M | Hold |
253,422
| – | – | 14.95% | 3 |
|
|
2023
Q3 | $19.3M | Hold |
253,422
| – | – | 47.73% | 1 |
|
|
2023
Q2 | $16.6M | Buy |
253,422
+12,500
| +5% | +$820K | 18.44% | 3 |
|
|
2023
Q1 | $14.4M | Hold |
240,922
| – | – | 16.67% | 3 |
|
|
2022
Q4 | $5.61M | Hold |
240,922
| – | – | 6.55% | 3 |
|
|
2022
Q3 | $8.07M | Hold |
240,922
| – | – | 9.37% | 3 |
|
|
2022
Q2 | $6.38M | Hold |
240,922
| – | – | 9.38% | 3 |
|
|
2022
Q1 | $7.08M | Hold |
240,922
| – | – | 7.27% | 4 |
|
|
2021
Q4 | $20.6M | Hold |
240,922
| – | – | 14.7% | 4 |
|
|
2021
Q3 | $17.9M | Hold |
240,922
| – | – | 3.01% | 3 |
|
|
2021
Q2 | $22.5M | Buy |
+240,922
| New | +$22.5M | 4.39% | 4 |
|